In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak.
about
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.Acinetobacter baumannii: emergence of a successful pathogenAzithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.Global challenge of multidrug-resistant Acinetobacter baumanniiCation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results.In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.Frequency, risk factors, and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India.Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii.In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.Geographical patterns in antimicrobial resistance of acinetobacter in clinical isolatesReliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.Transferable antibiotic resistance in multiresistant nosocomial Acinetobacter baumannii strains from seven clinics in the Slovak and Czech Republics.Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital.Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis.Successful treatment of Acinetobacter meningitis with meropenem and rifampicin.The study of formulated Zoush ointment against wound infection and gene expression of virulence factors Pseudomonas aeruginosa.
P2860
Q33970910-6C7F1881-DBFF-47BD-BD45-DB79D65EF3E6Q34109543-E1DF9E7C-015F-4690-94C0-8F5AE341957CQ34795807-BAFC3DF5-8F2B-4E81-9712-0FB0C477A493Q35947509-E63261F2-A9A0-440C-9D48-A9FDE054B613Q36059706-5D4CABA2-94A0-4236-9880-FF20EC8C6D94Q36095081-F2418D05-FAE2-4FB9-9C54-C8E15BC26C7CQ36118781-AEE1A8D4-4246-4BAE-BC76-B8001CFB151CQ36465442-4401BB12-8F5A-47F1-8AAB-5D5A4DF030C8Q36612595-B8819804-B9C5-4816-8950-CC63B2E0CB42Q37345244-44BC658F-9FF8-48CB-8948-BF544515AF46Q37838117-3E43AC91-33B8-4B82-B0D4-29D291855936Q39476770-062DB1E6-C3BC-4E2A-8888-96E98F514C6DQ39584788-9DD31E69-CE24-4609-AEC5-C1167D8B2B43Q39677063-781DBEEE-9FEC-45A8-9B3A-FEC19E6E28E0Q40933983-3080E047-4AC6-4B74-AFA9-9BD1D5FBCD2DQ41038831-1D888C3F-51C2-4073-8308-258A023D8679Q42239726-0D8C0DBE-A4FB-439B-9D3A-068EC01F79A7Q43593188-EC34E553-13E4-4378-8CFE-38E9BFD5FF89Q43756833-652E3FFB-EB0C-4E80-B8E1-F6C5B6CE624DQ43835966-FEECCA1A-215D-4C36-AEC0-9832A0704129Q43951669-E73F60CE-0923-443C-8D48-1A3A37347CE5Q46620852-897976E4-9589-4145-9E35-670F907A951CQ55452010-D8827CDE-096C-4D84-8E5A-0D37C119F137
P2860
In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vitro activities of nontrad ...... intensive care unit outbreak.
@ast
In vitro activities of nontrad ...... intensive care unit outbreak.
@en
type
label
In vitro activities of nontrad ...... intensive care unit outbreak.
@ast
In vitro activities of nontrad ...... intensive care unit outbreak.
@en
prefLabel
In vitro activities of nontrad ...... intensive care unit outbreak.
@ast
In vitro activities of nontrad ...... intensive care unit outbreak.
@en
P2093
P2860
P921
P1476
In vitro activities of nontrad ...... intensive care unit outbreak.
@en
P2093
Appleman MD
Belzberg H
Heseltine PN
P2860
P304
P356
10.1128/AAC.44.4.1035-1040.2000
P407
P577
2000-04-01T00:00:00Z